Caroline Gaynor takes the helm at Irish Venture Capital Association

Caroline Gaynor has been appointed chair of the Irish Venture Capital Association, coinciding with its 40th anniversary. She emphasised scaling indigenous start-ups and strengthening R&D investment, noting that while tariffs are unlikely to impact Irish pharmaceutical manufacturing in the short term, a two-track industrial approach is essential. Gaynor brings deep experience in biopharmaceuticals and medtech from Lightstone Ventures, aiming to drive long-term innovation and sticky foreign investment in Ireland.

Read the full article.